Compare CCAP & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CCAP | UROY |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | Canada |
| Employees | 250 | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.9M | 601.8M |
| IPO Year | N/A | N/A |
| Metric | CCAP | UROY |
|---|---|---|
| Price | $13.18 | $4.40 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.86 | N/A |
| AVG Volume (30 Days) | 171.6K | ★ 2.2M |
| Earning Date | 05-13-2026 | 03-11-2026 |
| Dividend Yield | ★ 12.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $279.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $14.18 | $1,584.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.80 | $1.81 |
| 52 Week High | $16.04 | $5.52 |
| Indicator | CCAP | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 45.78 | 66.62 |
| Support Level | $13.15 | $3.54 |
| Resistance Level | $13.57 | $4.58 |
| Average True Range (ATR) | 0.31 | 0.23 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 9.90 | 91.62 |
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.